Gene editing for patients with severe sickle cell disease is to be made available in the UK, it was announced last week (31st January). NHS England estimates that around 50 patients a year are expected to receive the treatment, exa-cel (exagamglog...
3 days ago
A new study has shown that COVID booster injections were highly successful in sparing patients with suppressed immune systems from hospital admission – including people with lymphoid blood cancers. In spite of their weakened immune systems, 80% of...
3 days ago